Sagga, Baby Girl .
HRN: 26-09-47 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/28/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/28/2024
11/03/2024
IVT
82mg
Q24
Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes